Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             173 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2015
 114 S1 p. 80-86
7 p.
 artikel
2 Copyright 2015
 114 S1 p. iv-
1 p.
 artikel
3 Information for Authors 2015
 114 S1 p. iii-
1 p.
 artikel
4 OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck Clement, P.
 2015
 114 S1 p. 7-8
2 p.
 artikel
5 OC-004: A randomized trial of concomitant cisplatin-RT +/- induction TPF in locally advanced nasopharyngeal carcinomas Daoud, J.
 2015
 114 S1 p. 7-
1 p.
 artikel
6 OC-045: Best practices for supportive care during chemo-radiotherapy in head and neck cancer patients Bossi, P.
 2015
 114 S1 p. 26-27
2 p.
 artikel
7 OC-020: Computer-guided surgery simulation for mandibular reconstruction with fibula free flap Dassonville, O.
 2015
 114 S1 p. 14-15
2 p.
 artikel
8 OC-006: Concomitant treatment (CRT or cetuximab/RT) with or without induction TPF in Locally Advanced head and neck Ghi, Cancer M.G.
 2015
 114 S1 p. 8-9
2 p.
 artikel
9 OC-044: 'Cure' is a realistic goal in HPV-related oropharyngeal cancer with oligometastasis Huang, S.
 2015
 114 S1 p. 26-
1 p.
 artikel
10 OC-042: Definitive chemoradiotherapy: An alternative to surgery in stage III/IV squamous cell carcinoma of the oral cavity? Bertke, M.H.
 2015
 114 S1 p. 25-
1 p.
 artikel
11 OC-021: Development of a multivariable Normal Tissue Complication Probability (NTCP) model for tube feeding dependence Wopken, K.
 2015
 114 S1 p. 15-
1 p.
 artikel
12 OC-018: GORTEC randomized trial evaluating OTD70DERM on dermatitis in head and neck cancer undergoing RT cetuximab Tao, Y.
 2015
 114 S1 p. 13-14
2 p.
 artikel
13 OC-040: Hypopharynx carcinoma - the influence of IMRT and concurrent chemotherapy Hermanrud, T.
 2015
 114 S1 p. 24-
1 p.
 artikel
14 OC-007: Is accelerated radiotherapy alone equivalent to chemo-radiation in patients with moderate advanced HNSCC? Skladowski, K.
 2015
 114 S1 p. 9-
1 p.
 artikel
15 OC-014: Molecular screening for cancer treatment optimization in head and neck cancer (MOSCATO 01) Even, C.
 2015
 114 S1 p. 12-
1 p.
 artikel
16 OC-043: Morbidity and functional outcomes of different transoral supraglottic resections Piazza, C.
 2015
 114 S1 p. 25-26
2 p.
 artikel
17 OC-016: Patient reported outcomes (PRO) of RTOG 9003 Konski, A.
 2015
 114 S1 p. 12-13
2 p.
 artikel
18 OC-041: Pivotal trial results and EU comparison of 99mTc-Tilmanocept in sentinel node biopsy in head and neck cancer patients De Bree, R.
 2015
 114 S1 p. 25-
1 p.
 artikel
19 OC-008: POPART vs CPORT in squamous cell head and neck cancer: Results of a multicenter randomised study of the Dutch head and neck Study Group Langendijk, H.
 2015
 114 S1 p. 9-10
2 p.
 artikel
20 OC-017: Refining UICC TNM stage and prognostic groups for non-metastatic HPV-related oropharyngeal carcinomas O'Sullivan, B.
 2015
 114 S1 p. 13-
1 p.
 artikel
21 OC-019: Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy Rovira Casas, A.
 2015
 114 S1 p. 14-
1 p.
 artikel
22 OC-015: Therapeutic HPV vaccine increases sensitivity of poorly immunogenic tumor to anti-PD-1 monotherapy Pai, S.
 2015
 114 S1 p. 12-
1 p.
 artikel
23 OC-022: The results of second head and neck pathology screening campaign Reshetov, I.
 2015
 114 S1 p. 15-16
2 p.
 artikel
24 OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck Eriksen, J.G.
 2015
 114 S1 p. 10-
1 p.
 artikel
25 OC-003: What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis Blanchard, P.
 2015
 114 S1 p. 6-7
2 p.
 artikel
26 PD-036: Association of HPV/p16 status with efficacy and safety in pts with OPC in the phase 3 RT/cetuximab registration trial Bonner, J.A.
 2015
 114 S1 p. 21-22
2 p.
 artikel
27 PD-034: Data from Pet Neck and GSK trials: Regional and geographic variability in HPV-associated oropharyngeal cancer Mehanna, H.
 2015
 114 S1 p. 20-21
2 p.
 artikel
28 PD-028: FDG based dose painting in head and neck cancer: preliminary results of a phase I trial Rasmussen, J.H.
 2015
 114 S1 p. 17-18
2 p.
 artikel
29 PD-035: Outcomes following unilateral neck irradiation for oropharyngeal cancer stratified by HPV status Waldron, J.
 2015
 114 S1 p. 21-
1 p.
 artikel
30 PD-039: Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation Christianen, M.
 2015
 114 S1 p. 24-
1 p.
 artikel
31 PD-037: Prospective randomized adaptive dose-de-escalation-trial for the elective neck: acute toxicity and control Duprez, F.
 2015
 114 S1 p. 22-23
2 p.
 artikel
32 PD-038: Risk factors for recurrence after carbon ion therapy for adenoid cystic carcinoma: impact of the histologic subtypes Ikawa, H.
 2015
 114 S1 p. 23-24
2 p.
 artikel
33 PD-032: Sk(C)ip into the mouth He, Y.
 2015
 114 S1 p. 19-20
2 p.
 artikel
34 PD-029: Temporal stability and reproducibility of FDG-PET-based dose painting targets in head and neck cancer Vogelius, I.
 2015
 114 S1 p. 18-19
2 p.
 artikel
35 PD-030: The clinical relevance of standardised optic pathway delineation in radiotherapy treatment planning De Groot, C.
 2015
 114 S1 p. 19-
1 p.
 artikel
36 PD-033: Value of lymphatic mapping SPECT/CT for sentinel node biopsy in 37 patients with T1-T2N0 oral cancer Poissonnet, G.
 2015
 114 S1 p. 20-
1 p.
 artikel
37 PD-031: Video-assisted minimally invasive surgery in patients with thyroid tumors Polyakov, A.
 2015
 114 S1 p. 19-
1 p.
 artikel
38 PO-161: Abstract withdrawn 2015
 114 S1 p. 75-
1 p.
 artikel
39 PO-089: Adaptive radiotherapy in head and neck cancer Yahsi, Y.
 2015
 114 S1 p. 45-
1 p.
 artikel
40 PO-160: Adenoid cystic carcinoma of the head and neck: proposal for a simplified histopathological grading scheme Van Weert, S.
 2015
 114 S1 p. 75-
1 p.
 artikel
41 PO-081: A longitudinal study of follow-up activities after curative treatment for head and neck cancer Pagh, A.P.
 2015
 114 S1 p. 42-
1 p.
 artikel
42 PO-146: Anatomical substantiation of microsurgical autotransplantation of parathyroid glands Reshetov, I.
 2015
 114 S1 p. 70-
1 p.
 artikel
43 PO-095: An evaluation of IMPT versus rotational IMRT for nasopharyngeal carcinoma Williams, T.
 2015
 114 S1 p. 48-
1 p.
 artikel
44 PO-098: A re-evaluation of late mucosal toxicity: evidence for a mixed consequential-late effect? Hartley, A.
 2015
 114 S1 p. 49-
1 p.
 artikel
45 PO-152: A study of the dermatopathological patterns of cutaneous head and neck swellings, Kasr Al Aini Hospitals Fawzy, M.
 2015
 114 S1 p. 72-
1 p.
 artikel
46 PO-065: A 23-year retrospective review of patients with nasopharyngeal carcinoma Bonfill Abella, T.
 2015
 114 S1 p. 35-
1 p.
 artikel
47 PO-079: Base of tongue squamous cell carcinoma as potential nonsurgical pathology. Biological and clinical background Gevorkov, A.
 2015
 114 S1 p. 41-
1 p.
 artikel
48 PO-123: Bupivacaine lozenge induces no risk of toxic plasma concentration in healthy subjects and head/neck cancer patients Treldal, C.
 2015
 114 S1 p. 60-
1 p.
 artikel
49 PO-094: Can the mean dose delivered to the superficial parotid lobe predict xerostomia following RT in HNC? Nevens, D.
 2015
 114 S1 p. 48-
1 p.
 artikel
50 PO-096: Cetuximab(CET), 5-FU and cisplatin or carboplatin (CA) vs CET, paclitaxel and CA in metastatic head and neck cancer Friesland, S.
 2015
 114 S1 p. 48-49
2 p.
 artikel
51 PO-088: Chemoradiotherapy for poor/intermediate risk oropharyngeal carcinoma: First results of the ArCHIMEDEs study Harrop, V.
 2015
 114 S1 p. 44-45
2 p.
 artikel
52 PO-077: Chemotherapy with cetuximab for head and neck squamous cell carcinoma: a retrospective study Pinto, L.
 2015
 114 S1 p. 40-
1 p.
 artikel
53 PO-120: Clinical impact of metabolic and anatomic imaging in nasopharyngeal carcinoma treated with chemo-radiotherapy Ghosh Laskar, S.
 2015
 114 S1 p. 59-
1 p.
 artikel
54 PO-057: Clinical outcomes and patterns of failure following radiotherapy for paranasal sinus and nasal cavity tumours Prestwich, R.
 2015
 114 S1 p. 32-
1 p.
 artikel
55 PO-105: Clinical relevance of copy number abberrations in early (T1-2) oral cavity squamous cell carcinomas Van Kempen, P.
 2015
 114 S1 p. 52-
1 p.
 artikel
56 PO-099: Combination of mTOR targeting with cetuximab, and chemotherapy: a preclinical study on head and neck cancer Bozec, A.
 2015
 114 S1 p. 49-50
2 p.
 artikel
57 PO-103: Comparison of VEGF Expression in non malignant, premalignant lesion and squamous cell carcinoma of oral cavity Gupta, M.
 2015
 114 S1 p. 51-52
2 p.
 artikel
58 PO-121: Computer-aided quantitative interpretation to HIF-1a, c-MYC and p53 expression in oral submucous fibrosis Anura, A.
 2015
 114 S1 p. 59-60
2 p.
 artikel
59 PO-078: Concurrent Cisplatin-radiotherapy with or without induction chemotherapy in nasopharyngeal carcinoma Mnejja, W.
 2015
 114 S1 p. 40-41
2 p.
 artikel
60 PO-116: Confocal laser endomicroscopy in diagnosis and treatment of ENT lesions: a feasibility study, preliminary results Chantrain, G.
 2015
 114 S1 p. 57-
1 p.
 artikel
61 PO-138: Data from DETERMIN RCT: Patient preferences for commonly-used, head and neck cancerñspecific QOL questionnaires Mehanna, H.
 2015
 114 S1 p. 67-
1 p.
 artikel
62 PO-130: Disseminating best practice in oral care Thomson, M.
 2015
 114 S1 p. 63-
1 p.
 artikel
63 PO-119: Does adaptive threshold based MTV and SUL have predictive value in head-neck cancers treated with radiotherapy? Ozkaya Akagunduz, O.
 2015
 114 S1 p. 58-
1 p.
 artikel
64 PO-062: Dose-painting IMRT with chemotherapy for nasopharyngeal carcinoma: single institution retrospective study Netto, E.
 2015
 114 S1 p. 33-34
2 p.
 artikel
65 PO-134: Dose related efficacy of LMS-611 in Radiotherapy Induced Xerostomia ñ an ex vivo study Paterson, C.
 2015
 114 S1 p. 64-65
2 p.
 artikel
66 PO-126: Early percutaneous endoscopic gastrostomy and nutritional supplementation in H&N cancer: an Italian survey Trignani, M.
 2015
 114 S1 p. 61-
1 p.
 artikel
67 PO-071: ELAN Program: Personalized treatment according to geriatric assessment in elderly patients with head & neck cancer Ortholan, C.
 2015
 114 S1 p. 38-
1 p.
 artikel
68 PO-085: Evaluation of the impact of the oral cavity contour on dose and constraint compliance in head-and-neck IMRT Prieto, I.
 2015
 114 S1 p. 43-44
2 p.
 artikel
69 PO-100: E6 viral protein ratio correlates with outcomes in human papillomavirus related oropharyngeal cancer Hong, A.
 2015
 114 S1 p. 50-
1 p.
 artikel
70 PO-110: Excellent survival in patients with non-hypoxic, HPV-positive oropharyngeal squamous cell carcinoma Swartz, J.E.
 2015
 114 S1 p. 54-
1 p.
 artikel
71 PO-168: Experience in using radiofrequent thermoablation in tumors of the mouth Polyakov, A.
 2015
 114 S1 p. 78-
1 p.
 artikel
72 PO-070: Experience of induction chemotherapy in head and neck tumors ECIVb in Mexico City Villavicencio-Queijeiro, M.
 2015
 114 S1 p. 37-
1 p.
 artikel
73 PO-147: Facial nerve and its branches reconstruction during surgery for head and neck tumors Polyakov, A.
 2015
 114 S1 p. 70-
1 p.
 artikel
74 PO-111: FGFR1 is a potential therapeutic target in oral and oropharyngeal squamous cell carcinoma Koole, K.
 2015
 114 S1 p. 55-
1 p.
 artikel
75 PO-169: Fine needle aspiration biopsy of thyroid at the Institute of Oncology Aldenora Bello-S„o Luis-Brazil Silva, S.P.
 2015
 114 S1 p. 78-79
2 p.
 artikel
76 PO-083: Freedom from regional failure of contralateral neck with ipsilateral neck radiotherapy for node and tonsil cancer Raben, A.
 2015
 114 S1 p. 42-43
2 p.
 artikel
77 PO-141: Free flaps for head and neck reconstruction in the elderly: a retrospective analysis on 453 patients Grammatica, A.
 2015
 114 S1 p. 68-
1 p.
 artikel
78 PO-107: Gain of copy number of PIK3CA and MET in head and neck cancers (HNSCCs) Brauswetter, D.
 2015
 114 S1 p. 53-
1 p.
 artikel
79 PO-097: Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas Lim, A.
 2015
 114 S1 p. 49-
1 p.
 artikel
80 PO-154: Head and neck cancer case-control study: UK Biobank Macfarlane, T.V.
 2015
 114 S1 p. 72-73
2 p.
 artikel
81 PO-059: Head and neck cancer: challenges raised by the free movement of oral surgeons in the European Union Nasseripour, M.
 2015
 114 S1 p. 32-33
2 p.
 artikel
82 PO-137: Health-related quality of life in head and neck cancer patients Mäkitie, A.
 2015
 114 S1 p. 66-67
2 p.
 artikel
83 PO-150: Histopathologic features of irradiated and non-irradiated vessels in head and neck microvascular reconstruction Piazza, C.
 2015
 114 S1 p. 71-
1 p.
 artikel
84 PO-128: How does radiotherapy impact on swallowing in head and neck cancer? Short-term results of a prospective study Ursino, S.
 2015
 114 S1 p. 62-
1 p.
 artikel
85 PO-104: HPV 16 E7 seropositivity in head and neck squamous cell carcinoma compared to healthy controls Zahoor, T.
 2015
 114 S1 p. 52-
1 p.
 artikel
86 PO-066: Impact of intensity-modulated radiotherapy in the treatment of nasopharyngeal cancer: single center experience Bonomo, P.
 2015
 114 S1 p. 35-36
2 p.
 artikel
87 PO-086: IMRT in Nasopharyngeal carcinoma - Single institution - experience from a developing country Kainickal, C.
 2015
 114 S1 p. 44-
1 p.
 artikel
88 PO-073: Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients *70 years Strom, T.
 2015
 114 S1 p. 38-39
2 p.
 artikel
89 PO-075: Induction chemotherapy in locally advanced hypopharynx cancer: treatment outcomes and role of nutritional status Culié, D.
 2015
 114 S1 p. 39-40
2 p.
 artikel
90 PO-093: Influence on toxicity mucositis depending on contouring the oral cavity: our experience Marin, J.
 2015
 114 S1 p. 47-
1 p.
 artikel
91 PO-151: Initial experience on near-infrared guided surgery for sentinel lymph node biopsy for oral cavity carcinoma Carvalho, A.L.
 2015
 114 S1 p. 71-72
2 p.
 artikel
92 PO-076: Is there a dose-response relationship in loco-regional control or survival outcomes in tonsil cancer? Park, H.J.
 2015
 114 S1 p. 40-
1 p.
 artikel
93 PO-129: Late xerostomia in VMAT for oropharyngeal cancer: dosimetric analysis of parotids outside the PTV Schipani, S.
 2015
 114 S1 p. 62-63
2 p.
 artikel
94 PO-115: Limited value of MRI for response evaluation of the neck after radiotherapy ñ especially in p16-positive disease Lilja-Fischer, J.
 2015
 114 S1 p. 56-57
2 p.
 artikel
95 PO-087: Long-term outcome of 18F-FDG-PET-guided dose painting for head-and-neck cancer: matched case-controlled study Berwouts, D.
 2015
 114 S1 p. 44-
1 p.
 artikel
96 PO-165: Long-term results of locally-advanced and metastatic thyroid cancer surgical treatment Reshetov, I.
 2015
 114 S1 p. 77-
1 p.
 artikel
97 PO-060: Long term results with intensified intensity modulated radiotherapy for nasopharyngeal cancer treatment Bacigalupo, A.
 2015
 114 S1 p. 33-
1 p.
 artikel
98 PO-153: Losing teeth attenuate the anti-cancer defense of oral fluid Narges, M.
 2015
 114 S1 p. 72-
1 p.
 artikel
99 PO-132: Management of anemia in (chemo)radiotherapy for head and neck cancer: policies in EORTC centers Nuyts, S.
 2015
 114 S1 p. 64-
1 p.
 artikel
100 PO-157: Medullary thyroid cancer (MTC): improved survival with new imaging Andry, G.
 2015
 114 S1 p. 74-
1 p.
 artikel
101 PO-149: Methods of soft tissues defect restoration in surgical treatment of head and neck skin melanoma Reshetov, I.
 2015
 114 S1 p. 71-
1 p.
 artikel
102 PO-143: Microinvasive access to visceral autoflaps - microsurgical reconstruction laryngopharynx and upper third esophagus Polyakov, A.
 2015
 114 S1 p. 68-69
2 p.
 artikel
103 PO-142: Microsurgical reconstruction of the tissues of the oral cavity and pharynx by visceral flaps in cancer patients Polyakov, A.
 2015
 114 S1 p. 68-
1 p.
 artikel
104 PO-162: Multiple primary malignancies of thyroid and nasopharyngeal carcinoma Sellami, N.
 2015
 114 S1 p. 75-76
2 p.
 artikel
105 PO-135: Nasopharynx IMRT: DVH parameters of constrictor muscles and parotid glands correlated to dysphagia and xerostomia Deantonio, L.
 2015
 114 S1 p. 65-66
2 p.
 artikel
106 PO-124: New local anesthetic lozenge induces no risk of aspiration in healthy subjects and head/neck cancer patients Mogensen, S.
 2015
 114 S1 p. 60-61
2 p.
 artikel
107 PO-064: Nodal failures of nasopharyngeal cancer: a Tunisian experience Ghorbal, L.
 2015
 114 S1 p. 34-35
2 p.
 artikel
108 PO-090: Normal tissue complication probability based multicriteria optimized IMRT in head and neck cancer radiotherapy Wopken, K.
 2015
 114 S1 p. 45-46
2 p.
 artikel
109 PO-159: Orbit preservation with chemoradiation for orbit invasive cancer of the paranasal sinuses Amsbaugh, M.J.
 2015
 114 S1 p. 75-
1 p.
 artikel
110 PO-145: Oropharyngeal region reconstruction using bioengineered flaps Reshetov, I.
 2015
 114 S1 p. 69-70
2 p.
 artikel
111 PO-074: Outcome of patients with T1-T2 laryngeal carcinoma treated with laser surgery vs radiotherapy Holguin, F.
 2015
 114 S1 p. 39-
1 p.
 artikel
112 PO-117: Overestimation of tumor volume of laryngeal/hypopharyngeal cancer on MRI in clinical radiotherapy practice Jager, E.A.
 2015
 114 S1 p. 57-58
2 p.
 artikel
113 PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma Cupissol, D.
 2015
 114 S1 p. 76-77
2 p.
 artikel
114 PO-114: Performance of SPECT/CT compared to bone scan in the assessment of free-flap bone grafts in mandible reconstruction Ouvrier, M.J.
 2015
 114 S1 p. 56-
1 p.
 artikel
115 PO-092: Phase II study of TPF and cetuximab+RT in locally advanced laryngeal/hypopharyngeal carcinoma Arias, F.
 2015
 114 S1 p. 46-47
2 p.
 artikel
116 PO-139: Photodynamic therapy as an adjuvant treatment after TORS of recurrent SCC of the base of tongue Meulemans, J.
 2015
 114 S1 p. 67-
1 p.
 artikel
117 PO-156: Pitfalls for diagnosis of pigmented skin lesions Ribeiro Porfirio, L.
 2015
 114 S1 p. 73-74
2 p.
 artikel
118 PO-101: Podoplanin expression in oropharyngeal cancer influences staging and prognosis only in p16 negative tumors Broglie Daeppen, M.A.
 2015
 114 S1 p. 50-51
2 p.
 artikel
119 PO-063: Post-operative (chemo)radiotherapy for oral cavity squamous cell carcinoma: outcomes and patterns of failure Bayman, E.
 2015
 114 S1 p. 34-
1 p.
 artikel
120 PO-112: Prediction of local control using maximal standard uptake value in early glottic carcinoma Park, J.
 2015
 114 S1 p. 55-
1 p.
 artikel
121 PO-122: Pre-radiation feeding tube marks a poor prognostic subset of postoperative p16+ oropharyngeal cancer Verma, V.
 2015
 114 S1 p. 60-
1 p.
 artikel
122 PO-127: Prevention and treatment of oral mucositis in patients treated with chemoradiotherapy with head and neck cancer Mota, A.
 2015
 114 S1 p. 61-62
2 p.
 artikel
123 PO-131: Prevention of mucositis: episil® in a clinical setting for oral cancer patients undergoing definitive RT Söderström, K.
 2015
 114 S1 p. 63-64
2 p.
 artikel
124 PO-061: Primary Chemo-Radiotherapy outcomes for locally advanced head and neck cancers Dandamudi, R.
 2015
 114 S1 p. 33-
1 p.
 artikel
125 PO-058: Primary chemotherapy followed by Transoral Laser Microsurgery and early laryngeal squamous cell carcinoma Cossu Rocca, M.
 2015
 114 S1 p. 32-
1 p.
 artikel
126 PO-118: Prognostic role of FDG-PET metabolic parameters during radiotherapy for head and neck squamous cell carcinoma Min, M.
 2015
 114 S1 p. 58-
1 p.
 artikel
127 PO-109: Prognostic value of Connexin 43 expression in head and neck cancers Dános, K.
 2015
 114 S1 p. 54-
1 p.
 artikel
128 PO-167: Rational approches to surgical treatment of head and neck skin melanoma Polyakov, A.
 2015
 114 S1 p. 78-
1 p.
 artikel
129 PO-102: Reirradiation and cetuximab in patients with recurrent, unresectable previously irradiated head and neck cancer Milanovic, D.
 2015
 114 S1 p. 51-
1 p.
 artikel
130 PO-113: Role of 18F-FDG PET/CT in chemo-radiotherapy response of nasopharyngeal cancer Belgioia, L.
 2015
 114 S1 p. 55-56
2 p.
 artikel
131 PO-155: Second primary tumors in a cohort of almost 600 patients with head and neck cancer Cirauqui, B.
 2015
 114 S1 p. 73-
1 p.
 artikel
132 PO-068: Soft tissue necrosis in head and neck cancer patients treated with radiation therapy after transoral robotic surgery Lee, Y.H.
 2015
 114 S1 p. 36-37
2 p.
 artikel
133 PO-166: Special aspects of surgical treatment of mucosal melanoma affecting oral and nasal cavities Polyakov, A.
 2015
 114 S1 p. 77-78
2 p.
 artikel
134 PO-144: Test of calcium phosphate cement for reconstruction maxillofaciallis zones in vitro Polyakov, A.
 2015
 114 S1 p. 69-
1 p.
 artikel
135 PO-133: The effect of normal tissue doses on quality of life in nasopharyngeal carcinomas treated with 3D-CRT Akin, M.
 2015
 114 S1 p. 64-
1 p.
 artikel
136 PO-106: The Extracellular Matrix in head and neck cancer at the leading edge of invasive growth Van Obberghen-Schilling, E.
 2015
 114 S1 p. 52-53
2 p.
 artikel
137 PO-067: The impact of different radiotherapy techniques on treatment outcome of hypopharyngeal carcinomas Aydin, B.
 2015
 114 S1 p. 36-
1 p.
 artikel
138 PO-084: The pharmacokinetic characteristics of nimorazole in head and neck cancer patients treated in the DAHANCA-5 trial Metwally, M.A.H.
 2015
 114 S1 p. 43-
1 p.
 artikel
139 PO-108: The role of circulating HPV-16 DNA detection in HNSCC patients treated by definitive radiation or chemo-radiation Hajduk, A.B.
 2015
 114 S1 p. 53-54
2 p.
 artikel
140 PO-158: The Role of concomitant radiochemotherapy in Anaplastic Thyroid Carcinomas (ATC): A study of the Rare Cancer Network Sun, X.S.
 2015
 114 S1 p. 74-75
2 p.
 artikel
141 PO-069: The role of neoadjuvant chemotherapy in the treatment of nasopharyngeal carcinoma Kim, Y.
 2015
 114 S1 p. 37-
1 p.
 artikel
142 PO-082: To quantify dosimetric effects of adaptive radiotherapy for head and neck cancer Kara, E.
 2015
 114 S1 p. 42-
1 p.
 artikel
143 PO-125: Toxicity and feasibility of adjuvant chemotherapy in nasopharynx carcinoma: a retrospective study Winckler, P.
 2015
 114 S1 p. 61-
1 p.
 artikel
144 PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC Guigay, J.
 2015
 114 S1 p. 46-
1 p.
 artikel
145 PO-140: Transnasal endoscopic medial maxillectomy for maxillary and ethmoid sinus tumor- our three experience Wang, T.C.
 2015
 114 S1 p. 67-68
2 p.
 artikel
146 PO-080: Trends in irradiating the mucosae in cervical adenopathies from unknown primaries Thariat, J.
 2015
 114 S1 p. 41-42
2 p.
 artikel
147 PO-163: Videoassisted functional lateral neck dissection (VFLND) about metastases of hightgrade thyroid cancer (TC) Polyakov, A.
 2015
 114 S1 p. 76-
1 p.
 artikel
148 PO-148: Videoassisted resections of larynx with radio frequency thermal ablation in cancer patients Polyakov, A.
 2015
 114 S1 p. 70-71
2 p.
 artikel
149 PO-072: 7-year experience of 18FDG PET-CT, IMRT and IGRT in Nasopharyngeal carcinoma (NC) Ciérvide Jurío, R.
 2015
 114 S1 p. 38-
1 p.
 artikel
150 PO-136: 7-year experience with the use of PEG in head and neck cancer patients treated with Radiation Therapy García-Aranda Pez, M.
 2015
 114 S1 p. 66-
1 p.
 artikel
151 SP-054: Against the motion Blanchard, P.
 2015
 114 S1 p. 30-
1 p.
 artikel
152 SP-047: Against the motion Keilholz, U.
 2015
 114 S1 p. 27-28
2 p.
 artikel
153 SP-049: A stem cell therapy for xerostomia Coppes, R.P.
 2015
 114 S1 p. 28-
1 p.
 artikel
154 SP-013: Beyond parotid sparing with IMRT Oszahin, M.
 2015
 114 S1 p. 12-
1 p.
 artikel
155 SP-024: Biomarker driven clinical trials Machiels, J.P.
 2015
 114 S1 p. 16-
1 p.
 artikel
156 SP-010: Effect of tumour heterogeneity on treatment selection and failure Haddad, R.
 2015
 114 S1 p. 10-11
2 p.
 artikel
157 SP-053: For the motion Budach, V.
 2015
 114 S1 p. 30-
1 p.
 artikel
158 SP-046: For the motion Burtness, B.
 2015
 114 S1 p. 27-
1 p.
 artikel
159 SP-055: For the motion Vermorken, J.
 2015
 114 S1 p. 30-
1 p.
 artikel
160 SP-012: Image guided minimally invasive and robotic techniques for sinus and base of skull malignancies Nicolai, P.
 2015
 114 S1 p. 11-12
2 p.
 artikel
161 SP-026: Integrating functional imaging in clinical trials Grégoire, V.
 2015
 114 S1 p. 17-
1 p.
 artikel
162 SP-023: Lessons learned from running surgical clinical trials Mehanna, H.
 2015
 114 S1 p. 16-
1 p.
 artikel
163 SP-025: Model based approach for testing new radiation technologies, including particle therapies Langendijk, H.
 2015
 114 S1 p. 16-17
2 p.
 artikel
164 SP-002: Novel opportunities in cancer immunotherapy Coukos, G.
 2015
 114 S1 p. 6-
1 p.
 artikel
165 SP-050: Promising targets beyond EGFR Merlano, M.
 2015
 114 S1 p. 29-
1 p.
 artikel
166 SP-027: Response evaluation in a clinical trial Dietz, A.
 2015
 114 S1 p. 17-
1 p.
 artikel
167 SP-051: SBRT for oligometastatic disease Eriksen, J.
 2015
 114 S1 p. 29-
1 p.
 artikel
168 SP-001: The evolving role of surgery and the surgeon in the treatment of head and neck cancer Weber, R.
 2015
 114 S1 p. 6-
1 p.
 artikel
169 SP-052: The role of PD-L1/PD1 pathway in SCCHN Guigay, J.
 2015
 114 S1 p. 29-30
2 p.
 artikel
170 SP-048: Tissue Engineering and in-vivo-regeneration of salivary glands Rotter, N.
 2015
 114 S1 p. 28-
1 p.
 artikel
171 SP-011: What's new with sentinel nodes? McGurk, M.
 2015
 114 S1 p. 11-
1 p.
 artikel
172 SP-056: Why are elderly patients with locally advanced disease treated differently from younger patients? Klozar, J.
 2015
 114 S1 p. 30-31
2 p.
 artikel
173 Title Page 2015
 114 S1 p. ii-
1 p.
 artikel
                             173 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland